CLINICAL_TRIALS
research
· 2024-05-08
Clinical Trial Update: Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis [Phase 4]
Summary
Phase 4 clinical trial evaluating BaiDiZiYin ShenQiYiFei as an adjunctive treatment for pulmonary tuberculosis; currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing Chest Hospital | Conditions: Adjuvant, Treatment | Phase 4 | Status: RECRUITING